Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. VINGE ADVISES LATOUR (1)
Mandate

VINGE ADVISES LATOUR

June 17, 2015

Vinge has advised Latour Industries in connection with the acquisition of the Finnish group of companies, Produal. The Produal Group conducts operations relating to the construction of automation measurement technology.

As a result of the acquisition, Latour Industries has strengthened its position within automation measurement construction and energy efficiency within building structures. Through the acquisition, Latour’s net indebtedness has increased by EUR 43 million.

Vinge’s team consisted of Magnus Pauli and Daniel Lennartsson. PWC provided financial advice to Latour and the Finnish firm, Krogerus, provided Finnish law advice.

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

 On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

 SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026